ABEONA THERAPEUTICS INC. (ABEO)

5.92 -1.99% (-0.12)

Over 6M: +17.0%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

4 5 6 7
Mar Apr May Jun Jul Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Revenue: 0 Q3 '23 — Operating Cash Flow: -5.7M Q3 '23 — Free Cash Flow: -5.8M Q3 '23 — Net Income: -11.8M Q4 '23 — Revenue: 0 Q4 '23 — Operating Cash Flow: -9.2M Q4 '23 — Free Cash Flow: -9.3M Q4 '23 — Net Income: -16.6M Q1 '24 — Operating Cash Flow: -14.5M Q1 '24 — Free Cash Flow: -15.3M Q1 '24 — Net Income: -31.6M Q2 '24 — Operating Cash Flow: -12.7M Q2 '24 — Free Cash Flow: -13.4M Q2 '24 — Net Income: 7.4M Q3 '24 — Operating Cash Flow: -12.2M Q3 '24 — Free Cash Flow: -12.6M Q3 '24 — Net Income: -30.3M Q4 '24 — Operating Cash Flow: -16.6M Q4 '24 — Free Cash Flow: -17.2M Q4 '24 — Net Income: -9.3M Q1 '25 — Revenue: 0 Q1 '25 — Operating Cash Flow: -18.4M Q1 '25 — Free Cash Flow: -19.8M Q1 '25 — Net Income: -12M Q2 '25 — Revenue: 400K Q2 '25 — Operating Cash Flow: -18.8M Q2 '25 — Free Cash Flow: -21.7M Q2 '25 — Net Income: 108.8M Q3 '25 — Revenue: 0 Q3 '25 — Operating Cash Flow: -21.2M Q3 '25 — Free Cash Flow: -23.7M Q3 '25 — Net Income: -5.2M Q4 '25 — Revenue: 5.4M Q4 '25 — Operating Cash Flow: -18M Q4 '25 — Free Cash Flow: -19.1M Q4 '25 — Net Income: -20.5M Q1 '26 — Revenue: 8.7M Q1 '26 — Operating Cash Flow: -19.8M Q1 '26 — Free Cash Flow: -20.7M Q1 '26 — Net Income: -17.1M Q2 '26 — Revenue: 11.4M Q2 '26 — Operating Cash Flow: -17.5M Q2 '26 — Free Cash Flow: -18M Q2 '26 — Net Income: -20.2M -30M 0 30M 60M 90M 120M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 45.4%
OE margin -364.8%
Oper. margin -327.6%
ROIC -691.5%
Gross margin 67.1%
Accruals 7.6%
EBITDA margin -316.6%
FCF margin -319.5%
OCF margin -299.5%
Profit margin -246.4%
ROA -35.0%
ROCE -54.0%
ROE -49.1%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO growth 0.0%
RPO / sales —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -25.3×
Cash / Debt 5.2×
Debt payback 0.0 yr
Quick ratio 6.4×
Debt / Eq 0.22×
Cash runway 1.5 yr
F-score 3.9 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.0
Sales CAGR 4Y -10.3%
Sales Q/Q +2745.0%
EPS Y/Y -168.2%
Shares change +61.2%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS next Y —
Sales/sh Y/Y —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.